CA Stock MarketDetailed Quotes

MDP Medexus Pharmaceuticals Inc

Watchlist
  • 2.820
  • +0.220+8.46%
15min DelayMarket Closed Dec 20 16:00 ET
69.52MMarket Cap23.11P/E (TTM)

Medexus Pharmaceuticals Inc Key Stats

Medexus Pharmaceuticals Inc Q2 2025 Earnings Date

Currency:USDNov 7, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
26.34M
26.30M
-38.27K
Miss Est.
-14.56%
-13.27%
-0.15%
EPS
0.02
<0.01
-0.01
Miss Est.
+129.59%
+108.96%
-70.13%

Medexus Pharmaceuticals Inc Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 34.546M--
--2025/Q3-- / 36.008M--
Nov 7, 20242025/Q236.492M / 35.625M--
Aug 7, 20242025/Q137.455M / 36.666M--
Jun 25, 20242024/Q435.453M / 36.479M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 34.546M--
--2025/Q3-- / 36.008M--
Nov 7, 20242025/Q236.492M / 35.625M--
Aug 7, 20242025/Q137.455M / 36.666M--
Jun 25, 20242024/Q435.453M / 36.479M--

Unlock Free Earnings Estimates

Medexus Pharmaceuticals Inc Earnings Reports

Read more

Trending CA Stocks
Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.